Kite Pharma, Inc. Insider Trading for August 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for August 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | M | 1.35 | 10,000 | 13,500 | 385,394 | |
| Aug 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 54.38 | 1,600 | 87,008 | 75,507 | 77.1 K to 75.5 K (-2.08 %) |
| Aug 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 53.73 | 6,300 | 338,499 | 77,107 | 83.4 K to 77.1 K (-7.55 %) |
| Aug 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 52.69 | 2,100 | 110,649 | 83,407 | 85.5 K to 83.4 K (-2.46 %) |
| Aug 28 2015 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Buy | M | 1.35 | 10,000 | 13,500 | 85,507 | 75.5 K to 85.5 K (+13.24 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 139,000 | |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 61.83 | 671 | 41,488 | 5,218 | 5.9 K to 5.2 K (-11.39 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 61.16 | 4,918 | 300,785 | 5,889 | 10.8 K to 5.9 K (-45.51 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Sell | S | 60.26 | 3,411 | 205,547 | 10,807 | 14.2 K to 10.8 K (-23.99 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | VP Clinical Develop ... | Buy | M | 6.89 | 9,000 | 62,010 | 14,218 | 5.2 K to 14.2 K (+172.48 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 161,732 | |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 61.73 | 1,465 | 90,434 | 1,695 | 3.2 K to 1.7 K (-46.36 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 60.99 | 5,322 | 324,589 | 3,160 | 8.5 K to 3.2 K (-62.74 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 60.21 | 2,780 | 167,384 | 8,482 | 11.3 K to 8.5 K (-24.68 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 11,262 | 1.7 K to 11.3 K (+564.42 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 17.00 | 645 | 10,965 | 35,813 | |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 5,500 | 3,850 | 118,625 | |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 61.65 | 1,150 | 70,898 | 999 | 2.1 K to 999 (-53.51 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 60.99 | 3,439 | 209,745 | 2,149 | 5.6 K to 2.1 K (-61.54 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 60.15 | 1,556 | 93,593 | 5,588 | 7.1 K to 5.6 K (-21.78 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 17.00 | 645 | 10,965 | 7,144 | 6.5 K to 7.1 K (+9.92 %) |
| Aug 19 2015 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 5,500 | 3,850 | 6,499 | 999 to 6.5 K (+550.55 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Option Exercise | M | 0.38 | 9,000 | 3,420 | 114,000 | |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 74.01 | 690 | 51,067 | 1,017 | 1.7 K to 1 K (-40.42 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 73.03 | 1,857 | 135,617 | 1,707 | 3.6 K to 1.7 K (-52.10 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 72.33 | 2,784 | 201,367 | 3,564 | 6.3 K to 3.6 K (-43.86 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 71.19 | 3,669 | 261,196 | 6,348 | 10 K to 6.3 K (-36.63 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Buy | M | 0.38 | 9,000 | 3,420 | 10,017 | 1 K to 10 K (+884.96 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Option Exercise | M | 6.89 | 7,700 | 53,053 | 276,900 | |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Sell | S | 73.87 | 319 | 23,565 | 6,000 | 6.3 K to 6 K (-5.05 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Sell | S | 72.93 | 2,205 | 160,811 | 6,319 | 8.5 K to 6.3 K (-25.87 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Sell | S | 72.29 | 2,276 | 164,532 | 8,524 | 10.8 K to 8.5 K (-21.07 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Sell | S | 71.15 | 2,900 | 206,335 | 10,800 | 13.7 K to 10.8 K (-21.17 %) |
| Aug 04 2015 | KITE | Kite Pharma, Inc. | Chang David D | EVP, R&D, Chief Med ... | Buy | M | 6.89 | 7,700 | 53,053 | 13,700 | 6 K to 13.7 K (+128.33 %) |